Trellus Health (TRLS) Competitors GBX 0.56 -0.02 (-3.48%) (As of 12/20/2024 06:45 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors TRLS vs. IQAI, FDBK, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COGShould you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry. Trellus Health vs. IQ-AI Feedback DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Cambridge Cognition Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability. Which has stronger valuation & earnings, TRLS or IQAI? IQ-AI has higher revenue and earnings than Trellus Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrellus Health£35K25.61-£6.66M-£0.03-18.50IQ-AI£538.19K6.10N/AN/AN/A Does the MarketBeat Community believe in TRLS or IQAI? IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users. CompanyUnderperformOutperformTrellus HealthN/AN/AIQ-AIOutperform Votes666.67% Underperform Votes333.33% Does the media refer more to TRLS or IQAI? In the previous week, Trellus Health's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score. Company Overall Sentiment Trellus Health Neutral IQ-AI Neutral Which has more risk & volatility, TRLS or IQAI? Trellus Health has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500. Is TRLS or IQAI more profitable? Trellus Health has a net margin of 0.00% compared to IQ-AI's net margin of -77.52%. Trellus Health's return on equity of -35.08% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets Trellus HealthN/A -35.08% -22.76% IQ-AI -77.52%-140.75%-22.03% Do insiders & institutionals hold more shares of TRLS or IQAI? 19.3% of Trellus Health shares are held by institutional investors. 49.7% of Trellus Health shares are held by company insiders. Comparatively, 66.0% of IQ-AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryIQ-AI beats Trellus Health on 6 of the 10 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Trellus Health News Delivered to You Automatically Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRLS vs. The Competition Export to ExcelMetricTrellus HealthHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£896,000.00£196.58M£5.14B£1.91BDividend YieldN/A6.94%5.09%5.45%P/E Ratio-18.50540.3890.051,871.08Price / Sales25.61285.021,116.25393,610.87Price / Cash0.7647.1443.1028.67Price / Book0.065.074.782.81Net Income-£6.66M-£8.11M£120.31M£155.88M7 Day Performance-7.50%-0.95%-1.92%-2.02%1 Month Performance-16.54%5.83%13.65%21.69%1 Year Performance-82.38%6.32%28.34%29.83% Trellus Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRLSTrellus HealthN/AGBX 0.56-3.5%N/A-82.9%£896,000.00£35,000.00-18.5031Gap DownIQAIIQ-AIN/AGBX 1.40-12.5%N/A-63.0%£3.10M£538,190.00-13.676Gap UpFDBKFeedbackN/AGBX 17.75flatN/A-75.9%£2.37M£1.18M-71.0024DVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AGBX 0.35-33.3%N/AN/A£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware1.4374 of 5 starsGBX 2,300-1.7%GBX 2,700+17.4%+22.9%£812.82M£189.27M8,846.15734INSInstemN/AGBX 830flatN/AN/A£199.62M£61.63M5,928.57500News CoverageKOOKooth2.2888 of 5 starsGBX 169.50+0.9%GBX 585+245.1%-45.5%£61.83M£54.17M1,412.50478Positive NewsRENXRenalytixN/AGBX 9.50flatN/A-28.9%£15.76M£2.29M-40.63102News CoverageCOGCambridge CognitionN/AGBX 30.50-1.6%N/A-37.9%£12.79M£13.08M-751.2580News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies IQAI Competitors FDBK Competitors DVRG Competitors SENS Competitors EMIS Competitors CRW Competitors INS Competitors KOO Competitors RENX Competitors COG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TRLS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trellus Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trellus Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
